FABP4 and Obesity: In fact, a large number of studies have shown that plasma levels of FABP4 are increased in obesity and T2DM, and that circulating FABP4 concentration correlated with clinical outcomes, such as body mass index, insulin resistance, and dyslipidemia [33].